• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

塔里布队列人群中糖尿病和甲状腺疾病合并症的患病率及其决定因素。

The prevalence and determinants of diabetes mellitus and thyroid disorder comorbidity in Tabari cohort population.

机构信息

Gastrointestinal Cancer Research Center, Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.

Diabetes Research Center, Mazandaran University of Medical Sciences, Sari, Iran.

出版信息

Sci Rep. 2024 Jul 30;14(1):17577. doi: 10.1038/s41598-024-68569-3.

DOI:10.1038/s41598-024-68569-3
PMID:39080342
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11289382/
Abstract

Studies have shown that the co-occurrence of diabetes mellitus (DM) and thyroid dysfunction (TD) exacerbates diabetes complications and imposes a financial burden on the healthcare system. Therefore, this study aimed to investigate the prevalence of TD-DM comorbidity and its associated risk factors. This cross-sectional study was conducted on enrollment phase data of the TABARI cohort population which consisted of 10,255 adults aged between 35 to 70 years old residing in Sari, Mazandaran, Iran from 2015 to 2017. A total of 9939 out of 10,255 individuals (96.92%) entered the study. The prevalence of TD among T2DM patients was 13.2%. The prevalence of T2DM among patients with TD was 9.2%. Furthermore, the prevalence of TD-DM comorbidity in the overall population was 2.2%. Logistic regression analysis revealed that the odds of TD-DM comorbidity was significantly higher in women (OR 2.85; 95% CI 1.58-5.11), in the age group of 60-70 years (OR 9.62; 95% CI 3.69-25.10), in smokers (OR 2.32; 95% CI 1.19-4.52), in individuals with high waist circumference (WC) (OR 2.22; 95% CI 1.32-3.75), in individuals with low high-density lipoprotein (HDL) (OR 1.60; 95% CI 1.20-2.14), in individuals with high total cholesterol (TC) (OR 1.71; 95% CI 1.21-2.41), in individuals with high triglycerides (TG) (OR 1.79; 95% CI 1.27-2.51), and significantly lower in individuals with higher physical activity (PA) (OR 0.67; 95% CI 0.49-0.93). The present study demonstrated a prevalence of 2.2% in patients with both TD and T2DM. Additionally, female gender, older age, smoking, high WC, low HDL, high TC, high TG, and low PA were predictors of TD-DM comorbidity.

摘要

研究表明,糖尿病(DM)和甲状腺功能障碍(TD)同时发生会加重糖尿病并发症,并给医疗保健系统带来经济负担。因此,本研究旨在调查 TD-DM 共病的患病率及其相关危险因素。这项横断面研究是在 2015 年至 2017 年期间,对伊朗马赞达兰省萨里市年龄在 35 至 70 岁之间的 10255 名成年人的 TABARI 队列人群的入组阶段数据进行的。共有 10255 人中的 9939 人(96.92%)进入了研究。T2DM 患者中 TD 的患病率为 13.2%。TD 患者中 T2DM 的患病率为 9.2%。此外,总体人群中 TD-DM 共病的患病率为 2.2%。逻辑回归分析显示,TD-DM 共病的可能性在女性(OR 2.85;95%CI 1.58-5.11)、60-70 岁年龄组(OR 9.62;95%CI 3.69-25.10)、吸烟者(OR 2.32;95%CI 1.19-4.52)、腰围高(OR 2.22;95%CI 1.32-3.75)、高密度脂蛋白(HDL)低(OR 1.60;95%CI 1.20-2.14)、总胆固醇(TC)高(OR 1.71;95%CI 1.21-2.41)、甘油三酯(TG)高(OR 1.79;95%CI 1.27-2.51)个体中显著更高,而在体力活动(PA)较高的个体中显著更低(OR 0.67;95%CI 0.49-0.93)。本研究显示,TD 和 T2DM 患者的患病率为 2.2%。此外,女性、年龄较大、吸烟、高腰围、低 HDL、高 TC、高 TG 和低 PA 是 TD-DM 共病的预测因素。

相似文献

1
The prevalence and determinants of diabetes mellitus and thyroid disorder comorbidity in Tabari cohort population.塔里布队列人群中糖尿病和甲状腺疾病合并症的患病率及其决定因素。
Sci Rep. 2024 Jul 30;14(1):17577. doi: 10.1038/s41598-024-68569-3.
2
Prevalence of anemia and related factors among Tabari cohort population: a cross-sectional study.塔巴里队列人群贫血的患病率及相关因素:一项横断面研究。
BMC Public Health. 2024 Oct 3;24(1):2702. doi: 10.1186/s12889-024-20220-6.
3
Tabari Cohort Profile and Preliminary Results in Urban Areas and Mountainous Regions of Mazandaran, Iran.塔巴里队列在伊朗马赞达兰的城市和山区的概况和初步结果。
Arch Iran Med. 2019 Jun 1;22(6):279-285.
4
Correlation between the triglyceride-to-high-density lipoprotein cholesterol ratio and other unconventional lipid parameters with the risk of prediabetes and Type 2 diabetes in patients with coronary heart disease: a RCSCD-TCM study in China.在中国冠心病患者中,甘油三酯/高密度脂蛋白胆固醇比值与其他非传统脂质参数与糖尿病前期和 2 型糖尿病风险的相关性:RCSCD-TCM 研究。
Cardiovasc Diabetol. 2022 Jun 3;21(1):93. doi: 10.1186/s12933-022-01531-7.
5
Prevalence of thyroid dysfunction and associated factors among adult type 2 diabetes mellitus patients, 2000-2022: a systematic review and meta-analysis.2000-2022 年成人 2 型糖尿病患者甲状腺功能障碍的患病率及相关因素:系统评价和荟萃分析。
Syst Rev. 2024 Apr 30;13(1):119. doi: 10.1186/s13643-024-02527-y.
6
Prevalence of self-reported coronary heart disease and its associated risk factors in Tabari cohort population.塔巴里队列人群中自我报告的冠心病患病率及其相关危险因素。
BMC Cardiovasc Disord. 2020 May 19;20(1):238. doi: 10.1186/s12872-020-01526-w.
7
[Body mass index, waist circumference and waist-to-height ratio associated with the incidence of type 2 diabetes mellitus: a cohort study].[体重指数、腰围及腰高比与2型糖尿病发病率的相关性:一项队列研究]
Zhonghua Yu Fang Yi Xue Za Zhi. 2016 Apr;50(4):328-33. doi: 10.3760/cma.j.issn.0253-9624.2016.04.009.
8
Prevalence of hysterectomy and its determinants in northern Iran: enrollment results of the Tabari cohort study.伊朗北部子宫切除术的流行情况及其决定因素:塔巴里队列研究的入组结果。
BMC Womens Health. 2024 Sep 11;24(1):502. doi: 10.1186/s12905-024-03338-y.
9
Value of simple clinical parameters to predict insulin resistance among newly diagnosed patients with type 2 diabetes in limited resource settings.在资源有限的环境下,用于预测新诊断 2 型糖尿病患者胰岛素抵抗的简单临床参数的价值。
PLoS One. 2021 Mar 31;16(3):e0248469. doi: 10.1371/journal.pone.0248469. eCollection 2021.
10
The association between waist-to-hip ratio (WHR) with diabetes in the PERSIAN Guilan cohort study population.伊朗裔 Guilan 队列研究人群中腰围臀围比(WHR)与糖尿病的关系。
BMC Endocr Disord. 2024 Jul 15;24(1):113. doi: 10.1186/s12902-024-01641-1.

引用本文的文献

1
Thyroid disorders and the incidence of type 2 diabetes: insights from a 10-year cohort study in Germany.甲状腺疾病与2型糖尿病的发病率:来自德国一项为期10年队列研究的见解
Endocr Connect. 2025 Jan 31;14(3). doi: 10.1530/EC-24-0554. Print 2025 Mar 1.

本文引用的文献

1
Diabetes- versus smoking-related thrombo-inflammation in peripheral artery disease.糖尿病与外周动脉疾病中的血栓炎症相关。
Cardiovasc Diabetol. 2023 Sep 21;22(1):257. doi: 10.1186/s12933-023-01990-6.
2
Elevated Free Thyroxine Levels Might Alter the Effect of the Lipid Profile on Insulin Resistance in Type 2 Diabetes Mellitus.游离甲状腺素水平升高可能会改变2型糖尿病患者血脂谱对胰岛素抵抗的影响。
Diagnostics (Basel). 2023 Aug 11;13(16):2656. doi: 10.3390/diagnostics13162656.
3
Important Hormones Regulating Lipid Metabolism.重要的脂质代谢调节激素。
Molecules. 2022 Oct 19;27(20):7052. doi: 10.3390/molecules27207052.
4
Links between Thyroid Disorders and Glucose Homeostasis.甲状腺疾病与血糖稳态的关联。
Diabetes Metab J. 2022 Mar;46(2):239-256. doi: 10.4093/dmj.2022.0013. Epub 2022 Mar 24.
5
A Study of Association of Thyroid Dysfunctions in Patients with Type 2 Diabetes Mellitus.2型糖尿病患者甲状腺功能障碍的相关性研究。
Maedica (Bucur). 2020 Jun;15(2):169-173. doi: 10.26574/maedica.2020.15.2.169.
6
Thyroid dysfunction and its association with microvascular complications in patients with type 2 diabetes mellitus in south India.印度南部2型糖尿病患者的甲状腺功能障碍及其与微血管并发症的关联。
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):615-617. doi: 10.1016/j.dsx.2020.05.005. Epub 2020 May 8.
7
Enrolment Phase Results of the Tabari Cohort Study: Comparing Family History, Lipids and Anthropometric Profiles Among Diabetic Patients.塔巴里队列研究的入组阶段结果:比较糖尿病患者的家族史、血脂和人体测量学特征
Osong Public Health Res Perspect. 2019 Oct;10(5):289-294. doi: 10.24171/j.phrp.2019.10.5.05.
8
Thyroid dysfunction prevalence and relation to glycemic control in patients with type 2 diabetes mellitus.2型糖尿病患者甲状腺功能障碍的患病率及其与血糖控制的关系。
Diabetes Metab Syndr. 2019 Jul-Aug;13(4):2513-2517. doi: 10.1016/j.dsx.2019.07.020. Epub 2019 Jul 9.
9
Prevalence of thyroid dysfunction in older Chinese patients with type 2 diabetes-A multicenter cross-sectional observational study across China.中国多中心横断面观察性研究:2 型糖尿病老年患者甲状腺功能障碍的流行情况。
PLoS One. 2019 May 2;14(5):e0216151. doi: 10.1371/journal.pone.0216151. eCollection 2019.
10
Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders.甲状腺功能紊乱与糖尿病:两种密切相关的疾病。
Endocr Rev. 2019 Jun 1;40(3):789-824. doi: 10.1210/er.2018-00163.